Products
Platform
Research
Market
Learn
Tatva Chintan Pharma Chem Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 124.52 | 118.02 | 108.59 | 85.94 | 83.87 |
| Other Income Qtr Cr | 1.01 | 1.16 | 0.72 | 0.04 | 0.38 |
| Operating Revenues Qtr | 123.52 | 116.86 | 107.86 | 85.90 | 83.49 |
Loading chart... | |||||
Operating Expenses Qtr | 101.30 | 99.53 | 98.91 | 78.84 | 77.90 |
Operating Profit Qtr | 22.22 | 17.33 | 8.95 | 7.06 | 5.59 |
EBITDA Qtr Cr | 23.22 | 18.48 | 9.67 | 7.10 | 5.96 |
Depreciation Qtr | 9.05 | 8.97 | 7.26 | 6.92 | 6.81 |
Net Profit Qtr | 9.92 | 6.65 | 1.03 | 0.14 | -0.66 |
Basic EPS Qtr | 4.24 | 2.84 | 0.44 | 0.06 | -0.29 |
Open Demat Account
Open Demat Account